Pharmaceutical group’s CFO to stand down
Register for free to receive latest news stories direct to your inboxRegister
Clinigen Group’s chief financial officer Nick Keher is to step down “to pursue other business interests”.
Keher joined the AIM-listed company in early 2019 after four years with RBC Capital Markets. He has stepped down from Clinigen’s board with immediate effect and will depart as CFO after a handover period.
The Burton-based pharmaceutical group has begun an external search for a permanent CFO while Richard Paling, the group’s financial controller since April 2017, will take the role on an interim basis.
Shaun Chilton, chief executive of Clinigen, said: “Nick has played a pivotal role in helping us to deliver on our ambitious strategy against the backdrop of the global COVID-19 pandemic and we wish him every success in the future.”
In June, Clinigen issued a profit warning which it blamed on the changing mix of its revenues away from its higher-margin Products division. Its shares fell 30% and nearly three months later remain 25% lower.